Exposed wires could puncture the artery and cause bleeding, inadequate perfusion and hemolysis, the FDA said in its Class I ...

The technology, called CARE, is expected to allow for faster development of AI models that can cover more health conditions.

Executives also addressed Medicaid concerns and competition from third-party suppliers of remanufactured surgical instruments ...

The company now expects a tariff charge of $100 million this year, down from a $200 million impact forecast on the company’s ...

The proclamation would push back implementation of the EPA’s rule on the carcinogenic gas for two years as the Trump ...

The company reported revenue of $37.2 million in the first quarter, up 39% year over year, but said it has faced challenges ...

The announcement follows reports that the dental equipment company was considering a sale after receiving takeover offers.

The company’s custom implants compete with devices from Medtronic, Johnson & Johnson and Globus Medical.

Whoop pushed back on the warning letter, claiming its blood pressure feature for a wearable wristband is for “wellness” and ...

The money will also help the company complete enrollment in a randomized controlled trial of patients with newly diagnosed ...

Medtronic said its market-leading LigaSure technology can now be used with its Hugo soft tissue robotic surgery system in ...

The defect has resulted in problems including a procedural delay, difficulty removing device fragments and bleeding, the FDA ...